Probiotics, gut microbiota and health.

The human gut is a huge complex ecosystem where microbiota, nutrients, and host cells interact extensively, a process crucial for the gut homeostasis and host development with a real partnership. The various bacterial communities that make up the gut microbiota have many functions including metabolic, barrier effect, and trophic functions. Hence, any dysbiosis could have negative consequences in terms of health and many diseases have been associated to impairment of the gut microbiota. These close relationships between gut microbiota, health, and disease, have led to great interest in using probiotics (i.e. live micro-organisms), or prebiotics (i.e. non-digestible substrates) to positively modulate the gut microbiota to prevent or treat some diseases. This review focuses on probiotics, their mechanisms of action, safety, and major health benefits. Health benefits remain to be proven in some indications, and further studies on the best strain(s), dose, and algorithm of administration to be used are needed. Nevertheless, probiotic administration seems to have a great potential in terms of health that justifies more research.

[1]  J. Olsson,et al.  Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans , 2010, Antonie van Leeuwenhoek.

[2]  M. Butel,et al.  Gnotobiotic Mouse Immune Response Induced by Bifidobacterium sp. Strains Isolated from Infants , 2007, Applied and Environmental Microbiology.

[3]  D. Serban Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics. , 2014, Cancer letters.

[4]  M. Goldacre,et al.  Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies , 2008, Diabetologia.

[5]  E. Zoetendal,et al.  Isolation of Bifidobacteria from Breast Milk and Assessment of the Bifidobacterial Population by PCR-Denaturing Gradient Gel Electrophoresis and Quantitative Real-Time PCR , 2008, Applied and Environmental Microbiology.

[6]  S. Cucchiara,et al.  Dominant genotypes in mucosa‐associated Escherichia coli strains from pediatric patients with inflammatory bowel disease , 2009, Inflammatory bowel diseases.

[7]  J. Bach,et al.  The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update , 2010, Clinical and experimental immunology.

[8]  G. Guyatt,et al.  Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. , 2013, The Cochrane database of systematic reviews.

[9]  Maija Saxelin,et al.  Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Haroun Shah,et al.  Gastrointestinal microflora studies in late-onset autism. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Xin Wang,et al.  The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. , 2013, Diagnostic microbiology and infectious disease.

[12]  L. Houghton,et al.  Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome. , 2012, Expert review of gastroenterology & hepatology.

[13]  H. Wichmann,et al.  Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life , 2004, Archives of Disease in Childhood.

[14]  S. Roos,et al.  Identification and characterization of antibiotic resistance genes in Lactobacillus reuteri and Lactobacillus plantarum , 2009, Journal of applied microbiology.

[15]  M. Camilleri Peripheral mechanisms in irritable bowel syndrome. , 2012, The New England journal of medicine.

[16]  J. Cannon,et al.  Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[17]  Willem M. de Vos,et al.  Genomics: A gut prediction , 2013, Nature.

[18]  M. Butel,et al.  Microbiota and Allergy: From Dysbiosis to Probiotics , 2012 .

[19]  Rafael Perera,et al.  A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome , 2009, BMC gastroenterology.

[20]  K. Alfaleh,et al.  Probiotics for prevention of necrotizing enterocolitis in preterm infants. , 2014, The Cochrane database of systematic reviews.

[21]  Dominique Turck,et al.  Supplementation of Infant Formula With Probiotics and/or Prebiotics: A Systematic Review and Comment by the ESPGHAN Committee on Nutrition , 2011, Journal of pediatric gastroenterology and nutrition.

[22]  O. Ruuskanen,et al.  The hygiene hypothesis of atopic disease--an extended version. , 2004, Journal of pediatric gastroenterology and nutrition.

[23]  M. Lomer,et al.  British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. , 2012, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[24]  C. la Vecchia,et al.  Probiotics Supplementation During Pregnancy or Infancy for the Prevention of Atopic Dermatitis: A Meta-analysis , 2012, Epidemiology.

[25]  C. Dupont,et al.  Mise en place de la flore intestinale du nouveau-né , 2007 .

[26]  J. Maldonado,et al.  Human Milk Probiotic Lactobacillus fermentum CECT5716 Reduces the Incidence of Gastrointestinal and Upper Respiratory Tract Infections in Infants , 2012, Journal of pediatric gastroenterology and nutrition.

[27]  H. Szajewska,et al.  Meta‐analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare‐associated diarrhoea in children , 2011, Alimentary pharmacology & therapeutics.

[28]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[29]  O. Ozdemir,et al.  Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data , 2010, Clinical and experimental immunology.

[30]  L. Dieleman,et al.  Probiotics in the Treatment of Human Inflammatory Bowel Diseases: Update 2011 , 2011, Journal of clinical gastroenterology.

[31]  Anne Salonen,et al.  Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. , 2010, Microbiology.

[32]  Pooneh Salari,et al.  A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. , 2012, Inflammation & allergy drug targets.

[33]  Susanne Hempel,et al.  Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. , 2012, JAMA.

[34]  B. Björkstén,et al.  Safety of D(-)-Lactic Acid Producing Bacteria in the Human Infant , 2005, Journal of pediatric gastroenterology and nutrition.

[35]  Gian Franco Gensini,et al.  Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report , 2012, Gut.

[36]  H. Szajewska,et al.  Meta‐analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment , 2010, Alimentary pharmacology & therapeutics.

[37]  D. Gevers,et al.  Horizontal transfer of tet(M) and erm(B) resistance plasmids from food strains of Lactobacillus plantarum to Enterococcus faecalis JH2-2 in the gastrointestinal tract of gnotobiotic rats. , 2007, FEMS microbiology ecology.

[38]  D. Mack Probiotics in Inflammatory Bowel Diseases and Associated Conditions , 2011, Nutrients.

[39]  S. Mazmanian,et al.  The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.

[40]  C. Zera,et al.  Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study , 2012, Archives of Disease in Childhood.

[41]  M. Tang,et al.  Probiotic use in clinical practice: what are the risks? , 2006, The American journal of clinical nutrition.

[42]  S. Nikfar,et al.  A Meta-Analysis on the Efficacy of Probiotics for Maintenance of Remission and Prevention of Clinical and Endoscopic Relapse in Crohn’s Disease , 2008, Digestive Diseases and Sciences.

[43]  H. Abriouel,et al.  Enterococci as probiotics and their implications in food safety. , 2011, International journal of food microbiology.

[44]  J. Jacquemin,et al.  Possible Role of Catheters in Saccharomyces boulardii Fungemia , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[45]  A. Armstrong,et al.  Effect of Nutrient Supplementation on Atopic Dermatitis in Children , 2012 .

[46]  T. Lherm,et al.  Seven cases of fungemia with Saccharomyces boulardii in critically ill patients , 2002, Intensive Care Medicine.

[47]  Liping Zhao,et al.  The gut microbiota, obesity and insulin resistance. , 2013, Molecular aspects of medicine.

[48]  J. Leonardi-Bee,et al.  Probiotics for treating eczema. , 2008, The Cochrane database of systematic reviews.

[49]  F. Doucet-Populaire,et al.  Tetracycline Resistance Mediated by tet(W), tet(M), and tet(O) Genes of Bifidobacterium Isolates from Humans , 2007, Applied and Environmental Microbiology.

[50]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[51]  J. Doré,et al.  Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.

[52]  Stefano Guandalini,et al.  Recommendations for probiotic use-2011 update. , 2011, Journal of clinical gastroenterology.

[53]  A. Akobeng,et al.  Probiotics for induction of remission in Crohn's disease. , 2008, The Cochrane database of systematic reviews.

[54]  D. Snydman The safety of probiotics. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  A. Marini,et al.  Allergic manifestations in very low‐birthweight infants: a 6‐year follow‐up , 2003, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[56]  P. Moayyedi,et al.  The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review , 2008, Gut.

[57]  S. Patole,et al.  Evidence-based guidelines for use of probiotics in preterm neonates , 2011, BMC medicine.

[58]  M. Kalliomäki,et al.  The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years , 2010, International Journal of Obesity.

[59]  S. Allen,et al.  Probiotics for treating acute infectious diarrhoea , 2010, The Cochrane database of systematic reviews.

[60]  Y. Sanz,et al.  Understanding the role of gut microbes and probiotics in obesity: how far are we? , 2013, Pharmacological research.

[61]  Taixiang Wu,et al.  Probiotics for preventing acute upper respiratory tract infections , 2015, The Cochrane database of systematic reviews.